MedinCell: Videoconference and Publication of the Results for the 2020-2021 Financial Year, on June 16, 2021
01 Giugno 2021 - 6:00PM
Business Wire
Regulatory News:
MedinCell (Paris:MEDCL) will hold a video conference for its
shareholders and the financial community on Wednesday, June 16, to
present the results for the 2020-2021 financial year which ended on
March 31, 2021:
- 6.30 pm CEST – Presentation and Q&A in French
- 7.30 pm CEST – Presentation and Q&A in English
- Link to connect: https://invest.medincell.com/conference/
An internet connection will be required to access the conference
and ask questions.
Modification of the date of the 2021 General Assembly
Medincell's General Assembly, initially scheduled for Friday,
September 10, 2021, will be held on Thursday, September 9, 2021, in
physical form*.
*subject to the applicable regulations
About MedinCell
MedinCell is a clinical stage pharmaceutical company that
develops a portfolio of long-acting injectable products in various
therapeutic areas by combining its proprietary BEPO® technology
with active ingredients already known and marketed. Through the
controlled and extended release of the active pharmaceutical
ingredient, MedinCell makes medical treatments more efficient,
particularly thanks to improved compliance, i.e. compliance with
medical prescriptions, and to a significant reduction in the
quantity of medication required as part of a one-off or chronic
treatment. The BEPO® technology makes it possible to control and
guarantee the regular delivery of a drug at the optimal therapeutic
dose for several days, weeks or months starting from the
subcutaneous or local injection of a simple deposit of a few
millimeters, fully bioresorbable. Based in Montpellier, MedinCell
currently employs more than 140 people representing over 25
different nationalities.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210601005782/en/
MedinCell David Heuzé Head of Communication
david.heuze@medincell.com +33 (0)6 83 25 21 86
NewCap Mathilde Bohin / Louis-Victor Delouvrier Investor
relations medincell@newcap.eu +33 (0)1 44 71 98 53
NewCap Nicolas Merigeau Media relations medincell@newcap.eu +33
(0)1 44 71 94 98
Grafico Azioni Medincell (EU:MEDCL)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Medincell (EU:MEDCL)
Storico
Da Apr 2023 a Apr 2024